Ratos makes take private offer for Biolin

The offer gives the company a market capitalisation of approximately SEK 277m. Biolin is currently listed on NASDAQ OMX Stockholm, Small Cap, and the offered price represents a premium of 32.2% compared to the volume-weighted average over the last 30 days. The acceptance period runs from 1 December to 21 December.

Ratos will support the existing growth strategy and aims to grow the company organically and through acquisitions.

ABG Sundal Collier is financial advisor to the investor while legal advice is provided by Mannheimer Swartling.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Viktor Lundvall on +44 20 7004 7476 or viktor.lundvall@incisivemedia.com

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Nordics
• Technology
• Buyouts
• Sweden
• Take Private